Cargando…

Pharmacokinetic Study of Mitomycin C with Emphasis on the Influence of Aging

Mitomycin C (MMC) at a dose of 8 mg/m(2) was administered by short intravenous infusion to 14 cancer patients. All patients had normal renal, hepatic, cardiac and bone marrow functions. The plasma level of MMC, which was determined by high‐performance liquid chromatography over a 24–h period after t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miya, Toshimichi, Sasaki, Yasutsuna, Karato, Atsuya, Saijo, Nagahiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 1992
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5918739/ https://www.ncbi.nlm.nih.gov/pubmed/1336497 http://dx.doi.org/10.1111/j.1349-7006.1992.tb02773.x

Ejemplares similares

Phase I and Pharmacokinetic Study of Paclitaxel by 24‐Hour Intravenous Infusion
por: Tamura, Tomohide, et al.
Publicado: (1994)

A Pharmacokinetic and Pharmacodynamic Analysis of CPT‐11 and Its Active Metabolite SN‐38
por: Sasaki, Yasutsuna, et al.
Publicado: (1995)

A Randomized Cross‐over Study of High‐dose Metoclopramide plus Dexamethasone versus Granisetron plus Dexamethasone in Patients Receiving Chemotherapy with High‐dose Cisplatin
por: Ohmatsu, Hironobu, et al.
Publicado: (1994)

Phase I Study of Paclitaxel by Three‐hour Infusion: Hypotension Just after Infusion Is One of the Major Dose‐limiting Toxicities
por: Tamura, Tomohide, et al.
Publicado: (1995)

CPT‐11: Population Pharmacokinetic Model and Estimation of Pharmacokinetics Using the Bayesian Method in Patients with Lung Cancer
por: Yamamoto, Nobuyuki, et al.
Publicado: (1994)

A Limited Sampling Model for Estimating Pharmacokinetics of CPT‐11 and Its Metabolite SN‐38
por: Sasaki, Yasutsuna, et al.
Publicado: (1995)

Pharmacokinetics of Mitomycin C Following Hepatic Arterial Chemoembolization With Gelfoam
por: Ding, Jin Wen, et al.
Publicado: (1992)

Inhibition of Colony Formation of Drug‐resistant Human Tumor Cell Lines by Combinations of Interleukin‐2‐activated Killer Cells and Antitumor Drugs
por: Ohtsu, Atsushi, et al.
Publicado: (1989)

The Mechanism of the Difference in Cellular Uptake of Platinum Derivatives in Non‐small Cell Lung Cancer Cell Line (PC‐14) and Its Cisplatin‐resistant Subline (PC‐14/CDDP)
por: Ohmori, Tohru, et al.
Publicado: (1993)

Validation and use of microdialysis for determination of pharmacokinetic properties of the chemotherapeutic agent mitomycin C - an experimental study
por: Sørensen, Olaf, et al.
Publicado: (2010)

Serial Measurement of Sister Chromatid Exchanges in the Peripheral Lymphocytes of Patients with Lung Cancer Receiving Chemotherapy in Relation to Bone Marrow Toxicity
por: Shinkai, Tetsu, et al.
Publicado: (1989)

LEVELS OF GLUTATHIONES TRANSFERASE π mRNA IN HUMAN LUNG CANCER CELL LINES CORRELATE WITH THE RESISTANCE TO CISPLATIN AND CARBOPLATIN
por: Nakagawa, Kazuhiko, et al.
Publicado: (1988)

Three Schedules of Recombinant Human Interleukin‐2 in the Treatment of Malignancy: Side Effects and Immunologic Effects in Relation to Serum Level
por: Sano, Tetsuro, et al.
Publicado: (1988)

Transconjunctival penetration of mitomycin C
por: Velpandian, T, et al.
Publicado: (2008)

Prediction from Creatinine Clearance of Thrombocytopenia and Recommended Dose in Patients Receiving (Glycolato‐O, O′)‐diammine Platinum (II) (NSC 375101D)
por: Sasaki, Yasutsuna, et al.
Publicado: (1990)

The Influence of Phacoemulsification on Surgical Outcomes of Trabeculectomy with Mitomycin-C for Uveitic Glaucoma
por: Nishizawa, Asaho, et al.
Publicado: (2016)

Effectiveness of an Immediate Mitomycin C Instillation in Patients with Superficial Bladder Cancer Receiving Periodic Mitomycin C Instillation
por: Jung, Seok Jin, et al.
Publicado: (2011)

Outcomes of Trabeculectomy With and Without Mitomycin C in Pseudoexfoliative Glaucoma Compared With Mitomycin C in Primary Open Angle Glaucoma
por: LOPES, Ana Sofia, et al.
Publicado: (2019)

Subcutaneous Administration of Recombinant Human Granulocyte Colony‐stimulating Factor (KRN8601) in Intensive Chemotherapy for Patients with Advanced Lung Cancer
por: Eguchi, Kenji, et al.
Publicado: (1990)

Mitomycin C hypoxic pelvic perfusion for unresectable recurrent rectal cancer: pharmacokinetic comparison of surgical and percutaneous techniques
por: Guadagni, Stefano, et al.
Publicado: (2017)

Mitomycin C. Current Status and Developments
por: Fox, B. W.
Publicado: (1980)

EFFECTS OF MITOMYCIN C ON HUMAN CHROMOSOMES
por: Cohen, Maimon M., et al.
Publicado: (1964)

Comparison of Surgical Outcomes between Trabeculectomy with Mitomycin C and Ahmed Valve Implantation with Mitomycin C in Eyes with Uveitic Glaucoma
por: Lee, Seung Yeop, et al.
Publicado: (2022)

Present Status and Problems on Molecular Targeted Therapy of Cancer
por: Saijo, Nagahiro
Publicado: (2012)

The Role of Pharmacoethnicity in the Development of Cytotoxic and Molecular Targeted Drugs in Oncology
por: Saijo, Nagahiro
Publicado: (2013)

Diminishing the side effect of mitomycin C by using pH-sensitive liposomes: in vitro characterization and in vivo pharmacokinetics
por: Fang, Yi-Ping, et al.
Publicado: (2018)

Effect of photodynamic therapy in combination with mitomycin C on a mitomycin-resistant bladder cancer cell line.
por: Datta, S. N., et al.
Publicado: (1997)

Pegylated liposomal mitomycin C prodrug enhances tolerance of mitomycin C: a phase 1 study in advanced solid tumor patients
por: Golan, Talia, et al.
Publicado: (2015)

Highlights for ESMO 40: celebration review for lifetime achievement awards
por: Saijo, Nagahiro
Publicado: (2016)

Differential Toxicity of DNA Adducts of Mitomycin C
por: Bargonetti, Jill, et al.
Publicado: (2010)

Outcomes of Photorefractive Keratectomy with Intraoperative Mitomycin-C
por: Ghoreishi, Mohammad, et al.
Publicado: (2009)

No effects of mitomycin-C in primary trabeculectomies in Sweden
por: Ayala, Marcelo
Publicado: (2018)

Mitomycin C and decarbamoyl mitomycin C induce p53-independent p21(WAF1/CIP1) activation
por: Cheng, Shu-Yuan, et al.
Publicado: (2016)

Phase I study of the mitomycin C analogue BMS-181174.
por: Macaulay, V. M., et al.
Publicado: (1998)

Comparative study of dacryocystorhinostomy with and without intraoperative application of Mitomycin C
por: Qadir, Maniah, et al.
Publicado: (2014)

A Cooperative Randomized Study on Tegafur plus Mitomycin C versus Combined Tegafur and Uracil plus Mitomycin C in the Treatment of Advanced Gastric Cancer
por: Kurihara, Minoru, et al.
Publicado: (1991)

Postoperative Bleb Management with Topical Mitomycin-C
por: Jonas, Jost B
Publicado: (2011)

Consequences of inadvertent intravitreal Mitomycin C injection
por: Mirshahi, Ahmad, et al.
Publicado: (2018)

Leftover mitomycin-c sponge causing blebitis
por: Khamar, Mayuri, et al.
Publicado: (2019)

Applications of Mitomycin C in Cornea and External Disease
por: Crespo, Marcos A., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_aev29s4vdp1o1rl80vaun2tkrq